Figure 3.
Inhibition of tumorosphere formation by EGFR inhibitors. (a) The cell viability was determined by MTT assay after 72 h incubation EGFR inhibitors, gefitinib; (b,c) Concentration‐dependent inhibition of tumorosphere formation by the EGFR inhibitors, gefitinib and PD153035; (d) HCT116 forms spheres in the presence or absence of gefitinib (×40).